These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 18612893

  • 21. [Pneumology. Anti-IgE antibodies in the treatment of asthma].
    Leuenberger P, Sauty A, Rochat T.
    Rev Med Suisse; 2007 Jan 10; 3(93):56-9. PubMed ID: 17354662
    [Abstract] [Full Text] [Related]

  • 22. Omalizumab as add-on therapy to inhaled steroids for asthma.
    Hadj Tahar A.
    Issues Emerg Health Technol; 2004 Jun 10; (58):1-4. PubMed ID: 15455487
    [Abstract] [Full Text] [Related]

  • 23. Many asthma patients experience persistent symptoms despite appropriate clinical and guideline-based treatment with inhaled corticosteroids.
    Mogil J.
    J Am Acad Nurse Pract; 2007 Sep 10; 19(9):459-70. PubMed ID: 17760570
    [Abstract] [Full Text] [Related]

  • 24. Changes of immunomodulatory cytokines associated with omalizumab therapy for severe persistent asthma.
    Shimizu Y, Dobashi K, Fueki N, Fueki M, Okada T, Tomioka S, Makino S, Mori M.
    J Biol Regul Homeost Agents; 2011 Sep 10; 25(2):177-86. PubMed ID: 21880206
    [Abstract] [Full Text] [Related]

  • 25. [Pratical aspects of anti-Ige therapy in severe allergic asthma].
    Taramarcaz P, Hauser C, Rochat T.
    Rev Med Suisse; 2007 Apr 25; 3(108):1050-2, 1054-5. PubMed ID: 17552257
    [Abstract] [Full Text] [Related]

  • 26. Reduction of the total IgE level by omalizumab in children and adolescents.
    Steiss JO, Strohner P, Zimmer KP, Lindemann H.
    J Asthma; 2008 Apr 25; 45(3):233-6. PubMed ID: 18415832
    [Abstract] [Full Text] [Related]

  • 27. Anti-IgE therapy of asthma.
    Chung KF.
    Curr Opin Investig Drugs; 2002 Aug 25; 3(8):1157-60. PubMed ID: 12211407
    [Abstract] [Full Text] [Related]

  • 28. Targeting IgE in asthma.
    Kuhl K, Hanania NA.
    Curr Opin Pulm Med; 2012 Jan 25; 18(1):1-5. PubMed ID: 22139745
    [Abstract] [Full Text] [Related]

  • 29. [Omalizumab, an anti-IgE monoclonal antibody to treat severe asthma].
    Michils A, Sternon J.
    J Pharm Belg; 2006 Jan 25; 61(3):83-7. PubMed ID: 17058881
    [Abstract] [Full Text] [Related]

  • 30. Asthma symptom re-emergence after omalizumab withdrawal correlates well with increasing IgE and decreasing pharmacokinetic concentrations.
    Slavin RG, Ferioli C, Tannenbaum SJ, Martin C, Blogg M, Lowe PJ.
    J Allergy Clin Immunol; 2009 Jan 25; 123(1):107-113.e3. PubMed ID: 19130931
    [Abstract] [Full Text] [Related]

  • 31. Response of older patients with IgE-mediated asthma to omalizumab: a pooled analysis.
    Maykut RJ, Kianifard F, Geba GP.
    J Asthma; 2008 Apr 25; 45(3):173-81. PubMed ID: 18415822
    [Abstract] [Full Text] [Related]

  • 32. Omalizumab: efficacy in allergic disease.
    Spector S.
    Panminerva Med; 2004 Jun 25; 46(2):141-8. PubMed ID: 15507883
    [Abstract] [Full Text] [Related]

  • 33. Unmet need in inadequately controlled asthma.
    Beasley R.
    Respirology; 2007 Nov 25; 12 Suppl 3():S18-21; discussion S45-7. PubMed ID: 17956515
    [Abstract] [Full Text] [Related]

  • 34. Does anti-IgE therapy help in asthma? Efficacy and controversies.
    Avila PC.
    Annu Rev Med; 2007 Nov 25; 58():185-203. PubMed ID: 17059361
    [Abstract] [Full Text] [Related]

  • 35. Add-on omalizumab improves day-to-day symptoms in inadequately controlled severe persistent allergic asthma.
    Humbert M, Berger W, Rapatz G, Turk F.
    Allergy; 2008 May 25; 63(5):592-6. PubMed ID: 18355388
    [Abstract] [Full Text] [Related]

  • 36. Omalizumab for severe asthma?
    Drug Ther Bull; 2006 Nov 25; 44(11):86-8. PubMed ID: 17089921
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Rationale for the major changes in the pharmacotherapy section of the National Asthma Education and Prevention Program guidelines.
    Kelly HW.
    J Allergy Clin Immunol; 2007 Nov 25; 120(5):989-94; quiz 995-6. PubMed ID: 17983867
    [Abstract] [Full Text] [Related]

  • 39. Pharmacodynamics of omalizumab: implications for optimised dosing strategies and clinical efficacy in the treatment of allergic asthma.
    Hochhaus G, Brookman L, Fox H, Johnson C, Matthews J, Ren S, Deniz Y.
    Curr Med Res Opin; 2003 Nov 25; 19(6):491-8. PubMed ID: 14594521
    [Abstract] [Full Text] [Related]

  • 40. Omalizumab: overview of pharmacology and efficacy in asthma.
    Ledford DK.
    Expert Opin Biol Ther; 2009 Jul 25; 9(7):933-43. PubMed ID: 19527111
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.